Literature DB >> 1884060

Prevention of venous thrombosis with minidose warfarin after joint replacement.

C Dale1, A Gallus, A Wycherley, S Langlois, D Howie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884060      PMCID: PMC1670507          DOI: 10.1136/bmj.303.6796.224

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Anticoagulants in the prevention of venous thromboembolism.

Authors:  A S Gallus
Journal:  Baillieres Clin Haematol       Date:  1990-07

2.  Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

Authors:  M M Bern; J J Lokich; S R Wallach; A Bothe; P N Benotti; C F Arkin; F A Greco; M Huberman; C Moore
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

3.  Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression.

Authors:  R McKenna; J Galante; F Bachmann; D L Wallace; P S Kaushal; P Meredith
Journal:  Br Med J       Date:  1980-02-23

4.  Venous thrombosis after elective hip replacement--the influence of preventive intermittent calf compression and of surgical technique.

Authors:  A Gallus; K Raman; T Darby
Journal:  Br J Surg       Date:  1983-01       Impact factor: 6.939

5.  Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.

Authors:  L Poller; A McKernan; J M Thomson; M Elstein; P J Hirsch; J B Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21
  5 in total
  7 in total

1.  The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.

Authors:  J M Walenga; D Hoppensteadt; R Pifarré; N L Fox; S Forman; D B Hunninghake; L Campeau; J A Herd; B J Hoogwerf; A Hickey; J L Probstfield; M L Terrin
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 2.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 3.  Unresolved issues in the prevention of venous thromboembolism.

Authors:  T Baglin
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators.

Authors:  J M Walenga; D Hoppensteadt; R Pifarré; M D Cressman; D B Hunninghake; N L Fox; M L Terrin; J L Probstfield
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

Review 5.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

Review 6.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 7.  Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.

Authors:  R L Bick
Journal:  Drugs       Date:  2000-09       Impact factor: 11.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.